GPLD1 and cancer: For example, PA is released by phospholipases D1 and D2 (PLD1/2) [10] from phospholipids, and the PLD signaling has been extensively studied in many pathological conditions such as cancer, inflammatory diseases, neurodegenerative disorders [31,32,33], and (neuro)toxicity.